Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $21.1000 (-4.95%) ($21.0450 - $21.1000) on Mon. Dec. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.1% (three month average) | RSI | 23 | Latest Price | $21.1000(-4.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.05% in a week (0% probabilities). VIXM(-34%) VXX(-26%) UNG(-10%) UUP(-9%) TLT(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.05% (StdDev 4.1%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $11.73(-44.41%) | Inflection Point | Yes | Resistance Level | $23.22 | 5 Day Moving Average | $22.19(-4.91%) | 10 Day Moving Average | $22.32(-5.47%) | 20 Day Moving Average | $23.22(-9.13%) | To recent high | -19.8% | To recent low | 66.4% | Market Cap | $1.568b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |